Hanoi, January 8, 2025, at the J.W Marriott Hotel in Hanoi– Hataphar Pharmaceutical has once again been recognized as one of Vietnam’s most prestigious pharmaceutical companies, securing its place in the Top 10 for the eighth time. This remarkable achievement underscores the company’s unwavering commitment to quality, innovation, and the health of the Vietnamese people.
For six decades, Hataphar has been at the forefront of the pharmaceutical industry, continuously investing in advanced manufacturing capabilities and product quality. The company’s dedication to meeting stringent international standards has been instrumental in its success.
The recent award is a testament to the collective efforts of Hataphar’s employees and leadership. Their tireless pursuit of excellence has propelled the company to new heights, solidifying its position as a trusted and reliable provider of pharmaceutical products.
Looking ahead, Hataphar is poised for even greater growth with the imminent launch of its state-of-the-art Hataphar High-Tech Pharmaceutical Plant, developed in collaboration with ASKA Pharmaceutical of Japan. This facility, adhering to the rigorous PICs/Japan-GMP standards, will enable Hataphar to penetrate demanding markets such as Europe and Japan. The company’s expertise in nanotechnology, herbal extracts, hormone-based drugs, and original pharmaceuticals will be instrumental in delivering high-quality products that meet the evolving needs of patients worldwide.
With a long-term vision and a strategic roadmap, Hataphar is consistently recognized for its achievements, as evidenced by numerous awards including the Top 100 Vietnamese Brands Award, the Golden Star of Vietnam Award, and recognition as one of Vietnam’s fastest-growing companies. These honors affirm Hataphar’s position as a leading force in the pharmaceutical industry and a beacon of innovation and sustainability.
